Designed for Market Leadership
Targeting a FREE position with unmatched risk/benefit ratio compared to current best selling products
Targeting a Massive Opportunity
Set to disrupt a €39bn market, fueled by megatrends like demand for natural, safer solutions, increased respiratory health awareness, and a shift toward self-care.
Market Positioning
Partnerships
We actively seek strategic partners for the commercialization of BREATHOX® in the EU and global licensing partners for the Osmovir platform as part of our global growth strategy.
BREATHOX®
Seeking BREATHOX® distribution partners in the EU or consumer health companies seeking line extensions.
Osmovir® Licensing
Seeking strategic global and regional licensing partnerships, allowing partners to launch line extensions in their own brands.
